Publication|Articles|October 6, 2025
Supplements and Featured Publications
- The Role of TEVIMBRA® (tislelizumab-jsgr) in First-Line ESCC Treatment
The Role of TEVIMBRA® (tislelizumab-jsgr) in First-Line ESCC Treatment
Advertisement
This Clinical Brief was sponsored by BeOne Medicines.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
House Votes to Extend ACA Subsidies, Eyes Turn to Senate
2
Tobacco Use Tied to Immunotherapy Response and Gastric Cancer Mortality
3
Influenza Vaccination in Older Adults Could Save Lives, Reduce Costs: Marco del Riccio, MD
4
Harnessing AI in Biomarker Analysis for Early-Onset CRC: Enrique Velazquez Villarreal, MD, PhD, MPH, MS
5
























































